Avelumab and pembrolizumab for the treatment of merkel cell carcinoma
Sandra D'Angelo et al.
The resurgence of immunotherapy in the treatment of cancer
Novel triple combination therapies for melanoma
The developments of genetic testing and personalized cancer vaccines for patients with skin cancer
KEYNOTE-045 – pembrolizumab as second-line treatment in urothelial carcinoma